Twist Bioscience Corp
(NAS:TWST)
$
46.78
-1.73 (-3.57%)
Market Cap: 2.78 Bil
Enterprise Value: 2.70 Bil
PE Ratio: 0
PB Ratio: 5.83
GF Score: 84/100 Twist Bioscience Corp at Goldman Sachs Global Healthcare Conference Transcript
Jun 14, 2022 / 05:40PM GMT
Release Date Price:
$27.46
(+4.81%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Hi, everybody. Welcome. My name is Matt Sykes. I'm the life science tools and diagnostics analyst at Goldman Sachs. I have the pleasure of hosting Twist Biosciences this morning, Emily Leproust, Chief Executive Officer and Co-Founder; and Jim Thorburn, Chief Financial Officer. Emily, Jim, thank you for joining.
James M. Thorburn
Twist Bioscience Corporation - CFO
Thank you.
Emily Marine Leproust
Twist Bioscience Corporation - Co-Founder, Chairman, President & CEO
Thank you.
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. Why don't I kind of let you set the stage firstly and then talk a little bit about some of the key accomplishments over the past 6 to 12 months and your most recent results and maybe some key opportunities and goals that investors should be focused on for the balance of the year now that we're sitting at midyear?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot